Cargando…
Valsartan in the Treatment of Heart Attack Survivors
Survivors of myocardial infarction (MI) are at high risk of disability and death. This is due to infarct-related complications such as heart failure, cardiac remodeling with progressive ventricular dilation, dysfunction, and hypertrophy, and arrhythmias including ventricular and atrial fibrillation....
Autor principal: | Jugdutt, Bodh I |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1993995/ https://www.ncbi.nlm.nih.gov/pubmed/17319456 |
Ejemplares similares
-
Clinical effectiveness of telmisartan alone or in combination therapy for controlling blood pressure and vascular risk in the elderly
por: Jugdutt, Bodh I
Publicado: (2010) -
Experimental Heart Failure Models and Their Pathophysiological Characterization
por: Becher, Peter Moritz, et al.
Publicado: (2016) -
Profile of sacubitril/valsartan in the treatment of heart failure: patient selection and perspectives
por: Yandrapalli, Srikanth, et al.
Publicado: (2017) -
Valsartan in the treatment of heart failure or left ventricular dysfunction after myocardial infarction
por: Bissessor, Naylin, et al.
Publicado: (2007) -
Focused Treatment of Heart Failure with Reduced Ejection Fraction Using Sacubitril/Valsartan
por: Liu, Rex C.
Publicado: (2018)